Aspen has identified four priorities for the firm as it seeks to transform from a regional generics business to a global specialty company. The group said its shift in focus was “vindicated by changes in the pharmaceutical industry, particularly pricing pressure in generics”.
Aspen Outlines Four Priorities As Focus Shifts To Global Specialty
Disposing of its Nutritionals business allows Aspen to fully focus on pharmaceuticals, while the firm is looking to drive organic growth with an emphasis on its Emerging Markets division, optimizing its complex manufacturing capabilities and seeking collaborations in territories where it “lacks sufficient critical mass”. These are among the measures Aspen has identified as it outlines four priorities for the firm, as the group shifts from being a regional generics company to a global specialty business.
